FDA Reversals on UniQure, Moderna Approvals Worry Investors

Investors are concerned about the fate of multiple experimental drugs for difficult-to-treat diseases following a series of recent rejections by…

FDA agrees to review Moderna's flu vaccine application after denial

A researcher works in the laboratory at Moderna's headquarters in Cambridge, Massachusetts, on March 26, 2024. Adam Glanzman | Bloomberg…